{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:32:02Z","timestamp":1790951522131,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002551","name":"Seoul National University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Thrombotic microangiopathy (TMA) is a life-threatening thrombotic disorder. Neutrophil extracellular traps (NETs) and activation of the contact system are known to promote and propagate the formation of thrombus. Our study assessed the prognostic values of multiple NET markers and a contact system activation marker in patients with clinically suspected TMA. Patients (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009138) with clinically suspected TMA were analyzed for the circulating levels of NET markers (neutrophil elastase, histone-DNA complexes, citrullinated histone H3 [Cit H3], and cell-free double-stranded DNA [dsDNA]); the contact system activation marker (activated factor XII [factor XIIa]); and other TMA-associated markers (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 [ADAMTS13] activity, von Willebrand factor antigen [vWF:Ag], von Willebrand factor ristocetin cofactor activity [vWF:Rco], and platelet counts). Low ADAMTS13 activity (hazard ratio [HR]: 4.85,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.033), high vWF:Rco (HR: 9.46,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.037), low platelet counts (HR: 7.45,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.017), and high histone-DNA complexes (HR: 8.43,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.015) were identified as independent markers of high mortality in multivariable Cox proportional hazards regression analysis. ADAMTS13, vWF:Rco, platelet counts, and histone-DNA complexes can be useful markers for identifying TMA patients at high risk of mortality.\n                  <\/jats:p>","DOI":"10.1007\/s00277-025-06612-7","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T07:44:55Z","timestamp":1758699895000},"page":"5433-5439","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Establishing prognostic markers associated with neutrophil extracellular traps and the activated contact system in thrombotic microangiopathy"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0351-8517","authenticated-orcid":false,"given":"Su Sung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja Yoon","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Yoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5839-7168","authenticated-orcid":false,"given":"Yujin","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Hwan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2401-3933","authenticated-orcid":false,"given":"Hyun Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"issue":"Suppl 1","key":"6612_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/ijlh.12671","volume":"39","author":"K Kottke-Marchant","year":"2017","unstructured":"Kottke-Marchant K (2017) Diagnostic approach to microangiopathic hemolytic disorders. Int J Lab Hematol 39(Suppl 1):69\u201375. https:\/\/doi.org\/10.1111\/ijlh.12671","journal-title":"Int J Lab Hematol"},{"issue":"7","key":"6612_CR2","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1056\/NEJMra1312353","volume":"371","author":"JN George","year":"2014","unstructured":"George JN, Nester CM (2014) Syndromes of thrombotic microangiopathy. N Engl J Med 371(7):654\u2013666. https:\/\/doi.org\/10.1056\/NEJMra1312353","journal-title":"N Engl J Med"},{"issue":"2","key":"6612_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/jth.13571","volume":"15","author":"M Scully","year":"2017","unstructured":"Scully M, Cataland S, Coppo P, de la Rubia J, Friedman KD, Kremer Hovinga J et al (2017) Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. J Thromb Haemost 15(2):312\u2013322. https:\/\/doi.org\/10.1111\/jth.13571","journal-title":"J Thromb Haemost"},{"issue":"1","key":"6612_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3324\/haematol.2018.198275","volume":"104","author":"EM Staley","year":"2019","unstructured":"Staley EM, Cao W, Pham HP, Kim CH, Kocher NK, Zheng L et al (2019) Clinical factors and biomarkers predict outcome in patients with immune-mediated thrombotic thrombocytopenic purpura. Haematologica 104(1):166\u2013175. https:\/\/doi.org\/10.3324\/haematol.2018.198275","journal-title":"Haematologica"},{"issue":"10","key":"6612_CR5","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1111\/jth.12681","volume":"12","author":"A Widemann","year":"2014","unstructured":"Widemann A, Pasero C, Arnaud L, Poullin P, Loundou AD, Choukroun G et al (2014) Circulating endothelial cells and progenitors as prognostic factors during autoimmune thrombotic thrombocytopenic purpura: results of a prospective multicenter French study. J Thromb Haemost 12(10):1601\u20131609. https:\/\/doi.org\/10.1111\/jth.12681","journal-title":"J Thromb Haemost"},{"issue":"36","key":"6612_CR6","doi-asserted-by":"publisher","first-page":"15880","DOI":"10.1073\/pnas.1005743107","volume":"107","author":"TA Fuchs","year":"2010","unstructured":"Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD Jr. et al (2010) Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A 107(36):15880\u201315885. https:\/\/doi.org\/10.1073\/pnas.1005743107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"6612_CR7","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1182\/blood-2012-02-412197","volume":"120","author":"TA Fuchs","year":"2012","unstructured":"Fuchs TA, Kremer Hovinga JA, Schatzberg D, Wagner DD, Lammle B (2012) Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood 120(6):1157\u20131164. https:\/\/doi.org\/10.1182\/blood-2012-02-412197","journal-title":"Blood"},{"key":"6612_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.thromres.2015.12.011","volume":"138","author":"HS Park","year":"2016","unstructured":"Park HS, Gu J, You HJ, Kim JE, Kim HK (2016) Factor XII-mediated contact activation related to poor prognosis in disseminated intravascular coagulation. Thromb Res 138:103\u2013107. https:\/\/doi.org\/10.1016\/j.thromres.2015.12.011","journal-title":"Thromb Res"},{"issue":"15","key":"6612_CR9","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1182\/blood.2022017074","volume":"141","author":"EM Sparkenbaugh","year":"2023","unstructured":"Sparkenbaugh EM, Henderson MW, Miller-Awe M, Abrams C, Ilich A, Trebak F et al (2023) Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease. Blood 141(15):1871\u20131883. https:\/\/doi.org\/10.1182\/blood.2022017074","journal-title":"Blood"},{"issue":"7","key":"6612_CR10","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/j.jtha.2025.03.038","volume":"23","author":"T Iba","year":"2025","unstructured":"Iba T, Levy JH, Maier CL, Helms J, Umemura Y, Moore H et al (2025) Updated definition and scoring of disseminated intravascular coagulation in 2025: communication from the ISTH SSC subcommittee on disseminated intravascular coagulation. J Thromb Haemost 23(7):2356\u20132362. https:\/\/doi.org\/10.1016\/j.jtha.2025.03.038","journal-title":"J Thromb Haemost"},{"key":"6612_CR11","doi-asserted-by":"publisher","first-page":"566678","DOI":"10.3389\/fmed.2021.566678","volume":"8","author":"N Henry","year":"2021","unstructured":"Henry N, Mellaza C, Fage N, Beloncle F, Genevieve F, Legendre G et al (2021) Retrospective and systematic analysis of causes and outcomes of thrombotic microangiopathies in routine clinical practice: an 11-Year study. Front Med (Lausanne) 8:566678. https:\/\/doi.org\/10.3389\/fmed.2021.566678","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"6612_CR12","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1182\/bloodadvances.2023011617","volume":"8","author":"N Yada","year":"2024","unstructured":"Yada N, Zhang Q, Bignotti A, Gralnek SH, Sosnovske D, Hogan K et al (2024) Targeting neutrophil extracellular trap accumulation under flow in patients with immune-mediated thrombotic thrombocytopenic purpura. Blood Adv 8(10):2536\u20132551. https:\/\/doi.org\/10.1182\/bloodadvances.2023011617","journal-title":"Blood Adv"},{"issue":"5","key":"6612_CR13","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.4049\/jimmunol.1301221","volume":"191","author":"R Tati","year":"2013","unstructured":"Tati R, Kristoffersson AC, Stahl AL, Rebetz J, Wang L, Licht C et al (2013) Complement activation associated with ADAMTS13 deficiency in human and murine thrombotic microangiopathy. J Immunol 191(5):2184\u20132193. https:\/\/doi.org\/10.4049\/jimmunol.1301221","journal-title":"J Immunol"},{"issue":"1","key":"6612_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.thromres.2008.11.020","volume":"124","author":"J Hyun","year":"2009","unstructured":"Hyun J, Kim HK, Kim JE, Lim MG, Jung JS, Park S et al (2009) Correlation between plasma activity of ADAMTS-13 and coagulopathy, and prognosis in disseminated intravascular coagulation. Thromb Res 124(1):75\u201379. https:\/\/doi.org\/10.1016\/j.thromres.2008.11.020","journal-title":"Thromb Res"},{"issue":"3","key":"6612_CR15","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/jth.14686","volume":"18","author":"M Peetermans","year":"2020","unstructured":"Peetermans M, Meyers S, Liesenborghs L, Vanhoorelbeke K, De Meyer SF, Vandenbriele C et al (2020) Von Willebrand factor and ADAMTS13 impact on the outcome of Staphylococcus aureus sepsis. J Thromb Haemost 18(3):722\u2013731. https:\/\/doi.org\/10.1111\/jth.14686","journal-title":"J Thromb Haemost"},{"issue":"9","key":"6612_CR16","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1111\/j.1538-7836.2011.04428.x","volume":"9","author":"LA Lotta","year":"2011","unstructured":"Lotta LA, Lombardi R, Mariani M, Lancellotti S, De Cristofaro R, Hollestelle MJ et al (2011) Platelet reactive conformation and multimeric pattern of von Willebrand factor in acquired thrombotic thrombocytopenic purpura during acute disease and remission. J Thromb Haemost 9(9):1744\u20131751. https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04428.x","journal-title":"J Thromb Haemost"},{"key":"6612_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.772607","volume":"8","author":"F Yang","year":"2021","unstructured":"Yang F, Tian J, Peng L, Zhang L, Liu J, Tian X et al (2021) Thrombocytopenia is an independent risk factor for the prognosis of thrombotic microangiopathy in Chinese patients with systemic lupus erythematosus. Front Med Lausanne 8:772607. https:\/\/doi.org\/10.3389\/fmed.2021.772607","journal-title":"Front Med Lausanne"},{"issue":"2","key":"6612_CR18","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/jth.15176","volume":"19","author":"J Sui","year":"2021","unstructured":"Sui J, Lu R, Halkidis K, Kocher NK, Cao W, Marques MB et al (2021) Plasma levels of S100A8\/A9, histone\/DNA complexes, and cell-free DNA predict adverse outcomes of immune thrombotic thrombocytopenic purpura. J Thromb Haemost 19(2):370\u2013379. https:\/\/doi.org\/10.1111\/jth.15176","journal-title":"J Thromb Haemost"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06612-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06612-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06612-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T08:19:06Z","timestamp":1763194746000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06612-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":18,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["6612"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06612-7","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board (IRB) of Seoul National University Hospital (SNUH) approved the study protocol. This study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no financial interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial interests"}},{"value":"All participants or their legal guardians provided written informed consent prior to their inclusion in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}